EICHOR
● Terminated
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
Condition: CTCL/ Mycosis Fungoides · CTCL · Mycosis Fungoides · Sponsor: Soligenix
About this study
To evaluate the use of HyBryte, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (17)
| Medical Dermatology Specialists | Phoenix, Arizona, United States | — |
| Mayo Clinic | Scottsdale, Arizona, United States | — |
| Therapeutics Clinical Research | San Diego, California, United States | — |
| University of South Florida | Tampa, Florida, United States | — |
| Northwestern University | Chicago, Illinois, United States | — |
| Dawes Fretzin Dermatology Group | Indianapolis, Indiana, United States | — |
| Washington University | St Louis, Missouri, United States | — |
| Rochester Skin Lymphoma Medical Group | Fairport, New York, United States | — |
| Columbia University Medical Center | New York, New York, United States | — |
| Accellacare (PMG) | Wilmington, North Carolina, United States | — |
| Penn State Health Hershey Medical Center | Hershey, Pennsylvania, United States | — |
| Hospital of the University of Pennsylvania | Philadelphia, Pennsylvania, United States | — |
+ 5 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06470451